<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Haemorrhoids &#8211; European Clinical Trials Information Network</title>
	<atom:link href="https://clinicaltrials.eu/meddra_pt/haemorrhoids/feed/" rel="self" type="application/rss+xml" />
	<link>https://clinicaltrials.eu</link>
	<description>Bridging Patients with Clinical Trials</description>
	<lastBuildDate>Fri, 19 Jun 2026 04:02:48 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png</url>
	<title>Haemorrhoids &#8211; European Clinical Trials Information Network</title>
	<link>https://clinicaltrials.eu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Study on Pain Relief for Hemorrhoids Using Ropivacaine and Ropivacaine Hydrochloride in Patients Undergoing Radiofrequency Treatment</title>
		<link>https://clinicaltrials.eu/trial/study-on-pain-relief-for-hemorrhoids-using-ropivacaine-and-ropivacaine-hydrochloride-in-patients-undergoing-radiofrequency-treatment/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Wed, 29 Apr 2026 14:28:57 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/trial/study-on-pain-relief-for-hemorrhoids-using-ropivacaine-and-ropivacaine-hydrochloride-in-patients-undergoing-radiofrequency-treatment/</guid>

					<description><![CDATA[This clinical trial is focused on studying the effects of a treatment for hemorrhoidal disease, a common condition that affects the veins in the lower rectum and anus, often causing discomfort and bleeding. The treatment being tested involves the use of ropivacaine, a medication that is injected to help manage pain. Ropivacaine is a type [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>This clinical trial is focused on studying the effects of a treatment for <em>hemorrhoidal disease</em>, a common condition that affects the veins in the lower rectum and anus, often causing discomfort and bleeding. The treatment being tested involves the use of <em>ropivacaine</em>, a medication that is injected to help manage pain. Ropivacaine is a type of anesthetic, which means it is used to numb a specific area of the body to reduce pain during and after medical procedures.</p>
<p>The purpose of this study is to evaluate the effectiveness of ropivacaine when used during a specific procedure called the <em>RAFAELO® procedure</em>, which is a method of treating hemorrhoids using radiofrequency energy. This procedure involves the use of heat to shrink the hemorrhoids, and the study aims to determine if injecting ropivacaine around the anal area can help reduce pain after the procedure. Participants in the study will receive either ropivacaine or a placebo, and their pain levels will be compared to see if the ropivacaine provides any additional benefit.</p>
<p>During the study, participants will undergo the RAFAELO® procedure and will be monitored for their pain levels six hours after the procedure. This time frame is chosen because the effects of ropivacaine typically last between six to twelve hours. The study will help determine if the use of ropivacaine is beneficial in managing pain for patients undergoing this type of hemorrhoid treatment.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
